Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder

International Journal of Mental Health Nursing
Blair BishopDaryle Deering

Abstract

Long-acting opioids are prescribed as part of treatment for opioid use disorders; methadone and buprenorphine are well researched and commonly prescribed for the treatment of opioid use disorder. Meta-analysis suggests that buprenorphine has a slightly poorer retention rate in treatment as compared to methadone. Benefits of buprenorphine/naloxone include greater ease in ceasing treatment and less use of illicit opioids while in treatment as compared to methadone. There are a number of qualitative and mixed-method studies that ask patients about their experiences of methadone maintenance and buprenorphine maintenance treatment. This research aimed to understand perspectives of receiving buprenorphine/naloxone for the treatment of opioid use disorder. A qualitative descriptive approach was used. Seven participants with a current diagnosis of opioid use disorder treated with buprenorphine/naloxone were interviewed. Thematic analysis extracted four themes: drivers for opioid substitution treatment change; readiness for buprenorphine/naloxone substitution treatment; absence of effect from buprenorphine/naloxone; and an increased sense of citizenship on buprenorphine/naloxone. This study identified a number of factors influencing par...Continue Reading

References

Oct 1, 1996·Australian and New Zealand Journal of Public Health·A Larson, G Bammer
Aug 15, 2000·Research in Nursing & Health·M Sandelowski
Dec 19, 2001·The Journal of Neuropsychiatry and Clinical Neurosciences·M SoykaS Kagerer
Oct 16, 2004·The Journal of Clinical Endocrinology and Metabolism·Niclaas BliesenerDietrich Klingmüller
Oct 27, 2004·Journal of Advanced Nursing·Gerard A Tobin, Cecily M Begley
Mar 21, 2008·Journal of Advanced Nursing·Satu Elo, Helvi Kyngäs
Sep 5, 2008·The American Journal on Addictions·Robert P SchwartzBarry S Brown
Jan 21, 2009·Annals of Internal Medicine·Mori J KrantzMark C P Haigney
Apr 21, 2009·Drug and Alcohol Review·Annie MaddenAdam R Winstock
Mar 24, 2010·Journal of Substance Abuse Treatment·Maxine L StitzerJessica Peirce
Jul 6, 2010·Journal of Substance Abuse Treatment·Cynthia L ArfkenCharles Roberts Schuster
Sep 8, 2010·Journal of Substance Abuse Treatment·Hayley PintoRichard Holland
Oct 20, 2010·The International Journal on Drug Policy·Adam R WinstockToby Lea
Jan 11, 2012·Qualitative Health Research·Julie Harris, Karen McElrath
May 9, 2012·International Journal of Mental Health Nursing·Daryle DeeringChristopher M A Frampton
Feb 19, 2013·The American Journal of Medicine·Michael J Brennan
Apr 10, 2013·Journal of Substance Abuse Treatment·Jan GryczynskiRobert P Schwartz
May 18, 2013·Medical Archives·Aneta Spasovska TrajanovskaAleksandar Cibisev
Jun 1, 2013·Journal of Addiction Medicine·Chinazo O CunninghamNancy L Sohler
Mar 25, 2014·Pain Management·Jennifer A Elliott, Eugene E Fibuch
Aug 27, 2014·Scientific Reports·Monica BaworZainab Samaan
Oct 30, 2014·The Australian and New Zealand Journal of Psychiatry·Phillipa HayWarren Ward
Oct 16, 2015·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Jeffrey A GudinSrinivas Nalamachu
Jan 23, 2016·Drug and Alcohol Dependence·Bobbi Jo H YarboroughCarla A Green

❮ Previous
Next ❯

Citations

Jun 24, 2020·Peptides·Richard J Bodnar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.